• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • Dopamine Agonists in Type 2 Diabetes

    Dopamine Agonists in Type 2 Diabetes by Fonseca, Vivian;

    Series: Oxford American Pocket Cards;

      • GET 10% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice GBP 5.99
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        2 861 Ft (2 725 Ft + 5% VAT)
      • Discount 10% (cc. 286 Ft off)
      • Discounted price 2 575 Ft (2 453 Ft + 5% VAT)

    2 861 Ft

    Availability

    Out of print

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Publisher Oxford University Press
    • Date of Publication 15 September 2011

    • ISBN 9780199773510
    • Binding Other published material
    • No. of pages1 pages
    • Weight 10 g
    • Language English
    • 0

    Categories

    Short description:

    This portable, ultra concise and up-to-date brochure provides key clinical insight as well as dosing and administration guidelines for newly FDA-approved dopamine agonist therapy for Type 2 diabetes.

    More

    Long description:

    Diabetes is the most prevalent metabolic disorder in the world. With many types of therapies available, including the mainstay insulin, the disease is manageable in most people. However, current anti-diabetes medications act primarily on peripheral end organs to regulate glucose and insulin levels. Dopamine agonist therapy, which targets the neuroendocrine patterns associated with insulin resistance, is a novel approach for diabetes treatment. Part of the Oxford American
    Pocket Cards series, this portable, ultra-concise and up-to-date brochure provides key clinical insight as well as dosing and administration guidelines for newly FDA-approved dopamine agonist therapy for Type 2 diabetes.

    To purchase this product, please contact U.S. Medical Sales at MedSales@oup.com

    More
    0